ASCO in Action

ASCO in Action provides the latest news and analysis related to critical policy issues affecting the cancer community, updates on the Association for Clinical Oncology’s ongoing advocacy efforts, and opportunities for members and others in the cancer care community to take action.

To sign up for advocacy alerts, log in to ASCO.org with your member or guest account, and visit the subscription center available under your account profile.

Tune in to the ASCO in Action podcast series for analysis and commentary on cancer policy and practice issues. The podcast is available through iTunes or Google Play.

Showing results for Medicare

November 23, 2021

On November 19, 2021, the Build Back Better Act passed the U.S. House of Representatives with a vote of 220-213. The legislation contains significant health care provisions, some of which are outlined here.

November 23, 2021

The Centers for Medicare & Medicaid Services (CMS) is applying the Merit-based Incentive Payment System (MIPS) automatic extreme and uncontrollable circumstances (EUC) policy to all individually eligible MIPS clinicians for the 2021 performance year (PY) due to COVID-19.

November 23, 2021

Due to the ongoing impact of COVID-19, the Centers for Medicare & Medicaid Services (CMS) is allowing clinicians, groups, virtual groups, and Alternative Payment Model (APM) Entities to request MIPS performance category reweighting for PY 2020 under the EUC policy until November 29, 2021. 

November 22, 2021

The American Medical Association's House of Delegates recently approved a resolution committing the AMA to strongly advocate against the application of sequestration to Medicare services, including to drugs administered under Medicare Part B, which would result in significant reimbursement cuts for Medicare providers. ASCO strongly advocated for the AMA HOD to pass this resolution.

November 5, 2021

On November 4, the Centers for Medicare & Medicaid Services (CMS) issued an interim final rule requiring COVID-19 vaccination of eligible staff at health care facilities that participate in the Medicare and Medicaid programs, and the Occupational Safety and Health Administration (OSHA) issued an Emergency Temporary Standard (ETS) as an interim final rule outlining the COVID-19 vaccination policy for employers of 100 or more staff.

November 3, 2021

On November 2, 2021, the Centers for Medicare & Medicaid Services (CMS) released the 2022 Hospital Outpatient Prospective Payment System (OPPS) final rule. The Association for Clinical Oncology (ASCO) will analyze the rule in greater detail in the coming days, while initial highlights are outlined here.

November 2, 2021

On November 2, 2021, the Centers for Medicare & Medicaid Services (CMS) released the 2022 Medicare Physician Fee Schedule (PFS) and Quality Payment Program (QPP) final rule. The Association for Clinical Oncology (ASCO) will analyze the rule in greater detail in the coming days, while initial highlights from the rule are outlined here.

September 22, 2021

In comments to the Centers for Medicare & Medicaid Services (CMS), the Association for Clinical Oncology (ASCO) expressed significant concerns that several provisions in the 2022 Hospital Outpatient Prospective Payment System (HOPPS) proposed rule have the potential to undermine access to cancer care for Medicare beneficiaries.

September 14, 2021

The Association for Clinical Oncology (ASCO) commented on provisions in the 2022 Medicare Physician Fee Schedule (MPFS) and Quality Payment Program (QPP) proposed rule that would impact cancer care for Medicare beneficiaries. The letter also offers perspective on CMS’ four-stage plan to transition CMS’ quality measurement enterprise to being fully digital by 2025 and how the agency can improve data collection and measurement to help advance health equity in the Medicare program.

September 14, 2021

On September 10, 2021, the Administration announced that the U.S. Department of Health and Human Services (HHS), through the Health Resources and Services Administration (HRSA), is making $25.5 billion in new funding available for health care providers affected by the COVID-19 pandemic.

September 14, 2021

On September 9, 2021, the Centers for Medicare & Medicaid Services posted new information on reprocessing claims for outpatient clinic visit services provided at excepted off-campus provider-based departments.

August 17, 2021

The American Society of Clinical Oncology and the Association for Clinical Oncology (collectively ASCO) released an in-depth analysis of the impact the 2022 Medicare Physician Fee Schedule (PFS) and Hospital Outpatient Prospective Payment System (OPPS) proposed rules—as well as pending sequestration cuts—could have on cancer care beginning January 1, 2022. 

August 6, 2021

The Association for Clinical Oncology (ASCO) commends the Biden Administration for proposing to rescind the Most Favored Nation (MFN) model from consideration. ASCO has consistently opposed the ill-advised MFN model, as it would have had a devastating impact on people with cancer. 

July 20, 2021

The Association for Clinical Oncology (ASCO) along with other health care organizations sent a letter to U.S. Senate leadership to convey their opposition to an extension of mandatory Medicare sequestration as a pay-for in any infrastructure package. The letter urges lawmakers to reconsider the potential use of Medicare funds included in the bipartisan infrastructure framework.

July 19, 2021

The Centers for Medicare & Medicaid Services (CMS) released its 2022 Hospital Outpatient Prospective Payment System (OPPS) proposed rule. Specific provisions that would impact the cancer care community are included here. 

Pages